Organ toxicity of systemic cancer therapy
Myelosuppression and G-CSF, alopecia, anthracycline and trastuzumab cardiotoxicity under the ESC 2022 cardio-oncology guideline, drug-induced pneumonitis, neuropathy, and renal, liver, ear, fertility and late effects.
Tier 1Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Systemic therapy toxicity depends on the drug class, cumulative dose and the patient's organ reserve. Learn the classic pairings: anthracyclines and heart, bleomycin and lung, cisplatin and kidney, ear and nerve, taxanes and vinca alkaloids and nerve.
- Myelosuppression is the commonest dose-limiting toxicity. Fever with neutropenia is an emergency: see Febrile neutropenia.
- Targeted drugs and antibody-drug conjugates have their own patterns (VEGF inhibitors and hypertension, trastuzumab deruxtecan and pneumonitis). Checkpoint inhibitors cause immune-related adverse events, covered in a separate note on checkpoint inhibitor toxicity.
Loading the rest of the note…
Finished reading?
Sources
- eviQ Cancer Treatments Online (antineoplastic drug information, cardiotoxicity, pneumonitis and neutropenia management)AU/NZCancer Institute NSW
- Therapeutic Guidelines: Oncology and Palliative Care (adverse effects of anticancer therapy)AU/NZTherapeutic Guidelines Ltd
- Lyon AR et al. 2022 ESC Guidelines on cardio-oncology. Eur Heart J 2022;43:4229-361European Society of Cardiology, 2022 (current, November 2026)
- Neilan TG et al. Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial. JAMA 2023;330:528-36JAMA, 2023
- Loprinzi CL et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 2020;38:3325-48American Society of Clinical Oncology, 2020 (current, November 2026)
- MBS item 73322: DPYD genotyping for fluoropyrimidine therapyAU/NZAustralian Government Department of Health, Disability and Ageing, 1 November 2025
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Personal emails, About story and Australian-style copy